Pedro Alfonso

Title: Innovations by Pedro Alfonso in Chemotactic Cytokines

Introduction

Pedro Alfonso is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and their applications in medical treatments.

Latest Patents

Pedro Alfonso holds a patent for "Polynucleotides encoding a human chemotactic cytokine I." This patent encompasses human chemotactic cytokine I polypeptides and the DNA (RNA) encoding such chemotactic cytokines. The patent also details a procedure for producing these polypeptides using recombinant techniques. Furthermore, it outlines methods for utilizing these chemotactic cytokines in the treatment of various medical conditions, including leukemia, tumors, chronic infections, autoimmune diseases, fibrotic disorders, wound healing, and psoriasis. The patent also discusses antagonists against these chemotactic cytokines and their therapeutic applications for treating rheumatoid arthritis, autoimmune diseases, and both chronic and acute inflammatory and infectious diseases. Additionally, diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides are included.

Career Highlights

Pedro Alfonso is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research in genetic therapies. His work has contributed to the understanding of chemotactic cytokines and their potential therapeutic uses.

Collaborations

Pedro has collaborated with notable colleagues, including Jian Ni and Guo-Liang Yu, to further enhance the research and development of innovative medical solutions.

Conclusion

Pedro Alfonso's contributions to the field of biotechnology, particularly through his patent on chemotactic cytokines, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and diagnostics.